Skip to content
Lower risk Drug recall · FDA · Published September 4, 2025

Zydus Entecavir Tablets Recall: Failed Impurity Risk

Zydus Pharmaceuticals recalls 1 mg Entecavir tablets due to failed impurity specifications. Patients should contact their doctor for guidance on safe use.

🇺🇸 FDA recall #D-0657-2025DrugZydus Pharmaceuticals ›
Take action

Contact the company

Recalling firmZydus Pharmaceuticals (USA) Inc73 Route 31 N · Pennington, NJ 08534-3601
✎ GovInfoNow plain-language explainer

Zydus Pharmaceuticals is recalling 1 mg Entecavir tablets that may have failed impurity or degradation tests. This could pose a risk to patients taking the medication. Read more at govinfonow.com/recall/31803-zydus-entecavir-tablets-recall-failed-impurity-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/31803-zydus-entecavir-tablets-recall-failed-impurity-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0657-2025

Cite this page

“Zydus Entecavir Tablets Recall: Failed Impurity Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31803-zydus-entecavir-tablets-recall-failed-impurity-risk. Based on FDA recall #D-0657-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0657-2025%22&limit=1).

Zydus Pharmaceuticals (USA) Inc., distributed by Zydus Lifesciences Ltd., voluntarily recalled Entecavir Tablets, USP, 1 mg because they failed impurity and degradation specifications, the Food and Drug Administration said on Sept. 4, 2025.

How to tell if you have it

  • Brand: Zydus Pharmaceuticals
  • Product: Entecavir Tablets, USP, 1 mg, 30 Tablets, Rx Only
  • Manufacturer: Zydus Lifesciences Ltd., Ahmedabad, India
  • Distributor: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534
  • NDC: 68382-921-06
  • Lot Code: E309377
  • Expiration Date: 11/30/2025
  • Quantity: 4440 bottles
  • Distribution: U.S. Nationwide

The hazard

The recalled Entecavir Tablets failed impurity and degradation specifications, according to the FDA recall record.

Context

GovInfoNow's records show Zydus Pharmaceuticals (USA) Inc has 53 other recalls on record since March 14, 2012. Other recent recalls of similar products include Zydus Mirabegron 25mg Tablets Recall (Aug. 5, 2026), Zydus Erythromycin Tablets Recall (April 29, 2026), and Zydus Recalls Icosapent Ethyl Capsules Due to Defects (March 9, 2026). Other recent recalls of similar products include Sagent Busulfan Injection Recall (May 4, 2026), Sun Pharmaceutical Fexofenadine 180mg Tablets Recall (June 1, 2026), and Alembic Fesoterodine Tablets Recall (Dec. 16, 2025).

How to tell if you have this one

Check for the product name 'Entecavir Tablets, USP, 1 mg, 30 Tablets, Rx Only' with NDC 68382-921-06. The lot number E309377 was manufactured in India and expires November 30, 2025.

  • Brand
    Zydus Pharmaceuticals
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    U.S. Nationwide
  • NDC
    68382-920-06, 68382-920-16, 68382-920-01, 68382-920-30, 68382-920-77, 68382-921-06, 68382-921-16, 68382-921-01, 68382-921-30, 68382-921-77
Recall numberProduct, codes & lotsQuantity
D-0656-2025Entecavir Tablets, USP, 0.5 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.; Lot E309376; Exp 11/30/20254344 bottles
D-0657-2025Entecavir Tablets, USP, 1 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-921-06.; Lot E309377, Exp 11/30/20254440 bottles
Based on the official FDA remedy

What to do — step by step

  1. Contact Your Doctor

    Your healthcare provider can advise on whether to stop using the medication and alternative options.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 20 days after the firm started it.

1. Firm started the recall: Sep 4, 202512. FDA classified it Class II: Sep 18, 202523. Published in FDA’s Enforcement Report: Sep 24, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

How can I check if my tablets are recalled?

Look for the NDC code 68382-921-06 and lot number E309377 on the packaging.

Similar recalls

Other Zydus Pharmaceuticals recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0657-2025 (September 4, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0657-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA